Ensysce Biosciences, Inc. (ENSC) vs IMMURON (IMRN)
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
- IMMURON IMRN 0.82 −3.53%
Ensysce Biosciences, Inc. and IMMURON are both Biotechnology companies. Ensysce Biosciences, Inc. and IMMURON are of similar size ($7.0M and $6.9M). IMMURON grew revenue faster over the last twelve months: −6.62% against −39.3%. IMMURON has the higher net margin (−262.7% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, IMMURON leads on 11 and Ensysce Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | ENSC | IMRN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 71.28% | 68.51% |
| Operating margin | (281.32%) | 0.00% | 0.00% |
| Net margin | (280.49%) | (262.71%) | 0.00% |
| Free cash flow margin | (196.76%) | 0.00% | 0.00% |
| Return on equity | (1,295.01%) | 0.00% | (51.96%) |
| Return on assets | (295.92%) | 0.00% | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack